Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 61.35 Thousand USD | -78.77% |
| 2021 | 289.02 Thousand USD | -51.79% |
| 2020 | 599.54 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | 0.0% |
| 2023 FY | - USD | -100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q2 | 1.93 Million USD | 54.6% |
| 2022 Q1 | 1.25 Million USD | 333.66% |
| 2022 FY | 61.35 Thousand USD | -78.77% |
| 2022 Q4 | 61.35 Thousand USD | -63.08% |
| 2022 Q3 | 166.2 Thousand USD | -91.42% |
| 2021 Q2 | 199.64 Thousand USD | 0.0% |
| 2021 FY | 289.02 Thousand USD | -51.79% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q4 | 289.02 Thousand USD | -31.2% |
| 2021 Q3 | 420.1 Thousand USD | 110.43% |
| 2020 Q4 | 599.54 Thousand USD | 0.0% |
| 2020 FY | 599.54 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 100.0% |
| AngioDynamics, Inc. | 5.91 Million USD | 100.0% |
| AtriCure, Inc. | 74.49 Million USD | 100.0% |
| Avinger, Inc. | 15.39 Million USD | 100.0% |
| Azenta, Inc. | 60.43 Million USD | 100.0% |
| BioLife Solutions, Inc. | 42.69 Million USD | 100.0% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 100.0% |
| Daxor Corporation | 755.65 Thousand USD | 100.0% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | 100.0% |
| Femasys Inc. | 6.7 Million USD | 100.0% |
| GlucoTrack, Inc. | 196 Thousand USD | 100.0% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 100.0% |
| Hologic, Inc. | 2.53 Billion USD | 100.0% |
| ICU Medical, Inc. | 1.7 Billion USD | 100.0% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 100.0% |
| KORU Medical Systems, Inc. | 4.44 Million USD | 100.0% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 100.0% |
| Innovative Eyewear, Inc. | - USD | NaN% |
| Masimo Corporation | 970 Million USD | 100.0% |
| Microbot Medical Inc. | 231 Thousand USD | 100.0% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | 100.0% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 100.0% |
| Nephros, Inc. | 1.83 Million USD | 100.0% |
| NovoCure Limited | 596.24 Million USD | 100.0% |
| NEXGEL, Inc. | 2.79 Million USD | 100.0% |
| NEXGEL, Inc. | 2.79 Million USD | 100.0% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 100.0% |
| OraSure Technologies, Inc. | 13.5 Million USD | 100.0% |
| Pro-Dex, Inc. | 13.54 Million USD | 100.0% |
| Pulse Biosciences, Inc. | 9.14 Million USD | 100.0% |
| Predictive Oncology Inc. | 2.85 Million USD | 100.0% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | 100.0% |
| QuidelOrtho Corporation | 2.61 Billion USD | 100.0% |
| Repligen Corporation | 711.8 Million USD | 100.0% |
| Sanara MedTech Inc. | 11.79 Million USD | 100.0% |
| STAAR Surgical Company | 35.83 Million USD | 100.0% |
| Sharps Technology, Inc. | - USD | NaN% |
| Utah Medical Products, Inc. | 342 Thousand USD | 100.0% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 100.0% |
| Jin Medical International Ltd. | 4.11 Million USD | 100.0% |